⚛️ Quantum Navigator
Lansdowne Partners
Overview
Lansdowne Partners
Investment management firm with venture investments in quantum technology
Investor Information
- Type: Hedge Fund / VC
- Founded: 1998
- Headquarters: London, UK
- Fund Size: $15B+ AUM
- Investment Stage: Series A to Series B ($20M-$50M)
- Website: https://www.lansdownepartners.com
Investment Focus
Technology, Healthcare, Quantum
Key People
Stuart Roden (Co-founder & CEO)
Notable Portfolio Companies
- Genomics
- Oxford Ionics
Related Resources
Key Information
Type
Hedge Fund / VC
Founded
1998
Headquarters
London, UK
Fund Size
$15B+ AUM
Investment Stage
Series A to Series B ($20M-$50M)
Focus Areas
Technology, Healthcare, Quantum
Key People
Related Resources
⚠️ Important Disclaimer
Information for Educational Purposes Only: All information about Lansdowne Partners is provided for informational and educational purposes only. This is not investment, financial, or professional advice.
No Investment Recommendations: Nothing on this page constitutes a recommendation to invest in any fund or company. Always conduct your own research and consult with qualified financial advisors before making investment decisions.
Accuracy: While we strive for accuracy, information may be incomplete or outdated. Please verify all details directly with Lansdowne Partners or through their official channels.
Third-Party Information: Portfolio company information and investment details are obtained from public sources and have not been verified for accuracy.